Rate and nature of complications of conduction system pacing compared with right ventricular pacing: Results of a propensity score-matched analysis from a multicenter registry.

Complications Conduction system pacing His bundle pacing Lead-related complications Left bundle branch area pacing Right ventricular pacing

Journal

Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 29 12 2022
revised: 14 02 2023
accepted: 05 03 2023
medline: 3 7 2023
pubmed: 12 3 2023
entrez: 11 3 2023
Statut: ppublish

Résumé

Conduction system pacing (CSP) using His bundle pacing (HBP) or left bundle branch area pacing (LBBAP) has emerged as an alternative to right ventricular pacing (RVP). Comparative data on the risk of complications between CSP and RVP are lacking. This prospective, multicenter, observational study aimed to compare the long-term risk of device-related complications between CSP and RVP. A total of 1029 consecutive patients undergoing pacemaker implantation with CSP (including HBP and LBBAP) or RVP were enrolled. Propensity score matching for baseline characteristics yielded 201 matched pairs. The rate and nature of device-related complications occurring during follow-up were prospectively collected and compared between the 2 groups. During a mean follow-up duration of 18 months, device-related complications were observed in 19 patients: 7 in RVP (3.5%) and 12 in CSP (6.0%) (P = .240). On dividing the matched cohort into 3 groups with similar baseline characteristics according to pacing modality (RVP, n = 201; HBP, n = 128; LBBAP, n = 73), patients with HBP showed a significantly higher rate of device-related complications than did patients with RVP (8.6% vs 3.5%; P = .047) and patients with LBBAP (8.6% vs 1.3%; P = .034). Patients with LBBAP showed a rate of device-related complications similar to that of patients with RVP (1.3% vs 3.5%; P = .358). Most of the complications observed in patients with HBP (63.6%) were lead related. Globally, CSP was associated with a risk of complications similar to that of RVP. Considering HBP and LBBAP separately, HBP showed a significantly higher risk of complications than did both RVP and LBBAP whereas LBBAP showed a risk of complications similar to that of RVP.

Sections du résumé

BACKGROUND BACKGROUND
Conduction system pacing (CSP) using His bundle pacing (HBP) or left bundle branch area pacing (LBBAP) has emerged as an alternative to right ventricular pacing (RVP). Comparative data on the risk of complications between CSP and RVP are lacking.
OBJECTIVE OBJECTIVE
This prospective, multicenter, observational study aimed to compare the long-term risk of device-related complications between CSP and RVP.
METHODS METHODS
A total of 1029 consecutive patients undergoing pacemaker implantation with CSP (including HBP and LBBAP) or RVP were enrolled. Propensity score matching for baseline characteristics yielded 201 matched pairs. The rate and nature of device-related complications occurring during follow-up were prospectively collected and compared between the 2 groups.
RESULTS RESULTS
During a mean follow-up duration of 18 months, device-related complications were observed in 19 patients: 7 in RVP (3.5%) and 12 in CSP (6.0%) (P = .240). On dividing the matched cohort into 3 groups with similar baseline characteristics according to pacing modality (RVP, n = 201; HBP, n = 128; LBBAP, n = 73), patients with HBP showed a significantly higher rate of device-related complications than did patients with RVP (8.6% vs 3.5%; P = .047) and patients with LBBAP (8.6% vs 1.3%; P = .034). Patients with LBBAP showed a rate of device-related complications similar to that of patients with RVP (1.3% vs 3.5%; P = .358). Most of the complications observed in patients with HBP (63.6%) were lead related.
CONCLUSION CONCLUSIONS
Globally, CSP was associated with a risk of complications similar to that of RVP. Considering HBP and LBBAP separately, HBP showed a significantly higher risk of complications than did both RVP and LBBAP whereas LBBAP showed a risk of complications similar to that of RVP.

Identifiants

pubmed: 36906165
pii: S1547-5271(23)00226-6
doi: 10.1016/j.hrthm.2023.03.009
pii:
doi:

Types de publication

Observational Study Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

984-991

Informations de copyright

Copyright © 2023 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Auteurs

Pietro Palmisano (P)

Cardiology Unit, "Card. G. Panico" Hospital, Tricase, Italy. Electronic address: dr.palmisano@libero.it.

Matteo Ziacchi (M)

Istituto di Cardiologia, IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy.

Gabriele Dell'Era (G)

Division of Cardiology, University of Eastern Piedmont, Maggiore della Carità Hospital, Novara, Italy.

Paolo Donateo (P)

Department of Cardiology, Arrhythmology Center, ASL 4 Chiavarese, Lavagna, Italy.

Ernesto Ammendola (E)

Department of Cardiology, Monaldi Hospital, Second University of Naples, Naples, Italy.

Giovanni Coluccia (G)

Cardiology Unit, "Card. G. Panico" Hospital, Tricase, Italy.

Alessandro Guido (A)

Cardiology Unit, "Card. G. Panico" Hospital, Tricase, Italy.

Giuseppe Pio Piemontese (GP)

Istituto di Cardiologia, IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy; Divisione di Cardiologia, Dipartimento di Malattie Cardiovascolari, AUSL Romagna, Ravenna, Italy.

Mirco Lazzeri (M)

Istituto di Cardiologia, IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy.

Chiara Ghiglieno (C)

Division of Cardiology, University of Eastern Piedmont, Maggiore della Carità Hospital, Novara, Italy.

Alessandro Veroli (A)

Division of Cardiology, University of Eastern Piedmont, Maggiore della Carità Hospital, Novara, Italy.

Roberto Maggi (R)

Department of Cardiology, Arrhythmology Center, ASL 4 Chiavarese, Lavagna, Italy.

Vincenzo Russo (V)

Department of Cardiology, Monaldi Hospital, Second University of Naples, Naples, Italy.

Anna Rago (A)

Department of Cardiology, Monaldi Hospital, Second University of Naples, Naples, Italy.

Gerardo Nigro (G)

Department of Cardiology, Monaldi Hospital, Second University of Naples, Naples, Italy.

Jacopo Senes (J)

Department of Cardiology, Arrhythmology Center, ASL 4 Chiavarese, Lavagna, Italy.

Giuseppe Patti (G)

Division of Cardiology, University of Eastern Piedmont, Maggiore della Carità Hospital, Novara, Italy.

Mauro Biffi (M)

Istituto di Cardiologia, IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy.

Michele Accogli (M)

Cardiology Unit, "Card. G. Panico" Hospital, Tricase, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH